The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Consensus treatment recommendations for late‐onset Pompe disease
Open accessAbstract
Introduction: Pompe disease is a rare, autosomal recessive disorder caused by deficiency of the glycogen‐degrading lysosomal enzyme acid alpha‐glucosidase. Late‐onset Pompe disease is a multisystem condition, with a heterogeneous clinical presentation that mimics other neuromuscular disorders. Methods: Objective is to propose consensus‐based treatment and management recommendations for late‐onset Pompe disease. Methods: A systematic review of the literature by a panel of specialists with expertise in Pompe disease was undertaken. Conclusions: A multidisciplinary team should be involved to properly treat the pulmonary, neuromuscular, orthopedic, and gastrointestinal elements of late‐onset Pompe disease. Presymptomatic patients with subtle objective signs of Pompe disease (and patients symptomatic at diagnosis) should begin treatment with enzyme replacement therapy (ERT) immediately; presymptomatic patients without symptoms or signs should be observed without use of ERT. After 1 year of ERT, patients' condition should be reevaluated to determine whether ERT should be continued. Muscle Nerve, 2012
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033 · cited 1×
“Highly purified, placentaderived acid alpha-glucosidase (GAA) enzyme was administered by intravenous infusion, taking advantage of the ability of lysosomes to internalize exogenous proteins by endocytosis.(12) Initial attempts at ERT encountered problems of immunogenicity, and there was limited availability of purifie…”
How humans walk: Bout duration, steps per bout, and rest duration
Orendurff, M. S. (2008) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2007.11.0197 · Cited by 306 · cited 1×
“The 6MWT, although useful in clinical trials, does not reflect the routine functional walking employed by most individuals.(102) This may explain why the improvements in 6MWT results documented in this”
Acid a-Glucosidase Deficiency (Glycogenosis Type II, Pompe Disease)
Raben, N., Plotz, P., & Byrne, B. (2002) · Current Molecular Medicine · doi:10.2174/1566524024605789 · Cited by 241
Cited by
A Broader View: Microbial Enzymes and Their Relevance in Industries, Medicine, and Beyond
Gurung, N., Ray, S., Bose, S., & Rai, V. (2013) · BioMed Research International · doi:10.1155/2013/329121 · Cited by 687
Lysosomal storage disease overview
Sun, A. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.11.39 · Cited by 271
Schoser, B., Stewart, A., Kanters, S., Hamed, A., Jansen, J., Chan, K., Karamouzian, M., & Toscano, A. (2017) · Journal of Neurology · doi:10.1007/s00415-016-8219-8 · Cited by 259
Metadata
- Authors
- Cupler, E. J., Berger, K. I., Leshner, R. T., Wolfe, G. I., Han, J. J., Barohn, R. J., Kissel, J. T., & of the AANEM CONSENSUS COMMITTEE ON LATE‐ONSET POMPE DISEASE
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2011-12-15
- Volume
- 45
- Issue
- 3
- Pages
- 319-333
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W2167525501
- Cited by
- 176
- References
- 3
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Consensus treatment recommendations for late‐onset Pompe disease. https://app.cochat.ai/papers/10.1002/mus.22329
- The paper
- Cupler, E. J., Berger, K. I., Leshner, R. T., Wolfe, G. I., Han, J. J., Barohn, R. J., Kissel, J. T., & of the AANEM CONSENSUS COMMITTEE ON LATE‐ONSET POMPE DISEASE. (2012). Consensus treatment recommendations for late‐onset Pompe disease. Muscle & Nerve. https://doi.org/10.1002/mus.22329
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.